Credit: CC0 Public Domain
Ladies in Europe are getting more cycles of in vitro fertilization (IVF) and intrauterine insemination (IUI), according to information provided today at the ESHRE 40th Annual Meeting in Amsterdam.
Initial information from the ESHRE European IVF Monitoring (EIM) Consortium exposes a stable and progressive increase in making use of Assisted Reproductive Technology (ART). In 2021, an overall of 1,103,633 ART treatment cycles were reported by 1,382 centers throughout 37 European nations– a 20% boost from the 919,364 cycles reported in 2020, remembering that this was the year COVID impacted the variety of treatment cycles.
Of these 2021 treatment cycles, there were 153,191 IVF, 418,069 intracytoplasmic sperm injection (ICSI), 368,464 frozen embryo replacement, 78,432 preimplantation hereditary screening, 79,510 egg contributions, 415 in vitro maturation of oocytes, and 5,552 cycles with frozen oocyte replacement. In addition, information from 1,441 organizations reported 148,194 IUI treatments where the partner’s semen was utilized (31 nations) and 48,583 IUI treatments where donor semen was utilized (23 nations). In overall, 28,768 fertility conservation interventions, consisting of oocyte, ovarian tissue, semen, and testicular tissue banking, were reported from 15 nations.
Scientific pregnancy rates per goal and per transfer stayed comparable in 2021 and 2020 for IVF (26.3% and 33.5 % in 2021 versus 25.4% and 33.2% in 2020) and for ICSI (23.9% and 33.5% in 2021 versus 25.2% and 33.0% 2020). Pregnancy rates per transfer for frozen embryo replacement with clients’ own embryos were somewhat greater in 2021 (37.0%) versus 2020 (36.0%), as were pregnancy rates per fresh embryo transfer from egg contributions (53.1% in 2021 versus 51.3% in 2020), while for frozen oocyte replacements the number reduced somewhat (45.5% in 2021 versus 45.7% in 2020).
This shows a 3.98% boost in making use of one embryo per transfer, increasing from 57.9% in 2020 to 60.5% in 2021. The percentage of singleton, twin, and triplet shipments was 90.4%, 9.5%, and 0.1% in 2021, respectively, compared to 88.9%, 10.9%, and 0.2% in 2020. Twin and triplet shipment rates after frozen embryo replacement were 6.9% and 0.1%, respectively, compared to 7.9% and 0.1% in 2020.
The lead author, Dr. Jesper Smeenk of Elisabeth-TweeSteden Hospital in Tilburg, Netherlands, mentioned, “The 25th ESHRE report on ART and IUI reveals a constant boost of reported treatment numbers and clinically helped recreation (MAR)-obtained live births in Europe. Being currently the biggest information collection on MAR in Europe, constant efforts to promote information collection and reporting pursue future quality assurance and efficiency of the information and provide greater openness and watchfulness in the field of reproductive medication.”
Teacher Dr. Karen Sermon, Chair of ESHRE, included, “This report highlights the significance of collective efforts and standardized reporting ahead of time reproductive medication. By boosting information collection practices, we intend to raise medical requirements and client results throughout Europe.”
Information collection and reporting
The ESHRE EIM report represents the biggest information collection on clinically helped recreation in Europe.